Drug Profile
Research programme: anticancer therapeutics - Pentagenic Pharmaceuticals
Alternative Names: SBA; Small biosynthetic anticancer agentLatest Information Update: 08 Feb 2007
Price :
$50
*
At a glance
- Originator Unknown
- Class
- Mechanism of Action Apoptosis stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer